Publications by authors named "Adam Doern"

Claim this Profile
E
Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines.
Stephen J Demarest, Jennifer Gardner, Michelle C Vendel, Eric Ailor, Suzanne Szak, Adam Doern

Biochemistry· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity.
Jianying Dong, Arlene Sereno, William B Snyder, Brian R Miller, Susan Tamraz, Adam Doern

J Biol Chem· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor response.
Jianying Dong, Stephen J Demarest, Arlene Sereno, Susan Tamraz, Emma Langley, Adam Doern

Mol Cancer Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.
Jennifer S Michaelson, Stephen J Demarest, Brian Miller, Aldo Amatucci, William B Snyder, Adam Doern

MAbs· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.
Adam Doern, Xianjun Cao, Arlene Sereno, Christopher L Reyes, Angelina Altshuler

J Biol Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis